Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus
- PMID: 925609
- PMCID: PMC2180971
- DOI: 10.1084/jem.146.5.1467
Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus
Abstract
By pretreatment with concanavalin A (Con A) both in vivo and in vitro genetically susceptible mice and their cultured macrophages have been converted to animals and cells which are phenotypically resistant to mouse hepatitus virus (MHV). Con A at 1.0 mg/mouse decreased the mortality from 100% to less than 40% by inducing a prominent inflammatory response, increasing the number of macrophages in the virus inoculation site, and producing a population of macrophages not uniformly susceptible to the virus. In addition, mediators derived from Con A-treated spleen cells conferred resistance to normally susceptible syngeneic macrophages to 100 TCID50 of MHV.
Similar articles
-
In vitro macrophage manifestation of cortisone-induced decrease in resistance to mouse hepatitis virus.J Exp Med. 1981 Mar 1;153(3):732-7. doi: 10.1084/jem.153.3.732. J Exp Med. 1981. PMID: 6265581 Free PMC article.
-
Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.Gut. 2013 Aug;62(8):1204-13. doi: 10.1136/gutjnl-2012-302239. Epub 2012 May 25. Gut. 2013. PMID: 22637698
-
Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.Lab Anim Sci. 1991 Apr;41(2):112-8. Lab Anim Sci. 1991. PMID: 1658437
-
Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus.J Immunol. 1987 May 15;138(10):3426-30. J Immunol. 1987. PMID: 2437194
-
Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.J Immunol. 1996 May 1;156(9):3342-9. J Immunol. 1996. PMID: 8617959
Cited by
-
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.J Exp Med. 1981 Oct 1;154(4):1150-63. doi: 10.1084/jem.154.4.1150. J Exp Med. 1981. PMID: 6270227 Free PMC article.
-
Seronegative immunity to SARS-CoV-2: a case study.Allergy Asthma Clin Immunol. 2022 Aug 30;18(1):80. doi: 10.1186/s13223-022-00715-w. Allergy Asthma Clin Immunol. 2022. PMID: 36042466 Free PMC article.
-
The molecular biology of coronaviruses.Adv Virus Res. 1983;28:35-112. doi: 10.1016/s0065-3527(08)60721-6. Adv Virus Res. 1983. PMID: 6362367 Free PMC article. Review.
-
In vitro acquisition of resistance against herpes simplex virus by permissive murine macrophages.Arch Virol. 1979;59(3):157-72. doi: 10.1007/BF01317412. Arch Virol. 1979. PMID: 222234 No abstract available.
-
Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.J Exp Med. 1987 Nov 1;166(5):1436-46. doi: 10.1084/jem.166.5.1436. J Exp Med. 1987. PMID: 3119759 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases